Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phreesia Inc (NY: PHR )

17.92 -0.23 (-1.27%)
Streaming Delayed Price Updated: 9:59 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Phreesia Inc

< Previous 1 2 3 4 Next >
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's session, 275 companies made new 52-week lows. 
Via Benzinga
Raymond James Maintains Outperform Rating for Phreesia: Here's What You Need To Know
Via Benzinga
Expert Ratings for Phreesia
Via Benzinga
Phreesia's Earnings: A Preview
Via Benzinga
What 8 Analyst Ratings Have To Say About Phreesia
Via Benzinga
Phreesia: Q1 Earnings Insights
Via Benzinga
Tesla To Rally Around 61%? Here Are 10 Analyst Forecasts For Monday
Jefferies boosted the price target for DoorDash, Inc. (NYSE: DASH) from $70 to $90. Jefferies analyst Brent Thill upgraded the stock from Underperform to Hold. DoorDash shares rose 2.7% to $84.40 in... 
Via Benzinga
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Preview: Phreesia
Via Benzinga
Analyst Expectations for Phreesia's Future
Via Benzinga
9 Analysts Have This to Say About Phreesia
Via Benzinga
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for... 
Via Benzinga
These Analysts Slash Their Forecasts On Phreesia Following Q2 Results
Phreesia, Inc. (NYSE: PHR) reported a wider-than-expected second-quarter loss. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Phreesia's Earnings: A Preview
Via Benzinga
Analyst Expectations for Phreesia's Future
Via Benzinga
Elliott Wave Technical Analysis: Phreesia Inc.
Looking for a clear five wave move to then look for longs. 
Via Talk Markets
Earnings Scheduled For September 6, 2023
Companies Reporting Before The Bell • Express (NYSE:EXPR) is projected to report quarterly loss at $11.11 per share on revenue of $440.72 million. 
Via Benzinga
Earnings Scheduled For May 31, 2023
Companies Reporting Before The Bell • CAE (NYSE:CAE) is projected to report quarterly earnings at $0.25 per share on revenue of $882.41 million. 
Via Benzinga
Analyst Expectations for Phreesia's Future
Via Benzinga
Analyst Ratings for Phreesia
Via Benzinga
Elliott Wave Technical Analysis: Phreesia Inc. - Thursday, April 20
Looking for upside to first break the base of the ending diagonal as additional confirmation. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Phreesia Gets Price Target Bumps By Analysts Following Q4 Results
Phreesia, Inc. (NYSE: PHR) reported results for its fourth quarter. Phreesia posted a quarterly loss of $0.72 per share, versus analysts’ expectations for a loss of $0.51 per share. The company’s... 
Via Benzinga
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose... 
Via Benzinga
Elliott Wave Technical Analysis: Phreesia Inc. - Wednesday, March 15
Looking for a break of wave (b) to have further confirmation. 
Via Talk Markets
Needham Remains Bullish On Phreesia & Udemy; Adds Both To Conviction List
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.